MitraClip therapy is the world’s first transcatheter mitral valve repair that is minimally invasive and has been used in over 50,000 patients worldwide. As Mitraclip is a well-established heart disease therapy, Heart South Cardiologists supports this technological breakthrough for some high-risk patients with mitral regurgitation (MR) or leaky mitral valve. The Mitraclip procedure is performed through a small incision in the groin wherein a tube is passed up through the leg vein to the right side of the heart. The tube is then passed in to the left side of the heart using a technique known as trans-septal puncture as seen below. This is a very specialized technique and gives us access to the mitral valve. The Mitraclip procedure is less invasive than traditional open-heart surgery and patients usually leave the hospital within 1 to 2 days. Mitraclip procedure is reserved for patients with severe mitral regurgitation (MR) or leaky mitral valve determined to be at high-risk for traditional open heart surgery. Therefore, each patient is evaluated by our Structural Heart Team to determine the best therapy and procedures, ensuring the clinical benefits greatly outweigh any possible risks.